Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Diletti

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 18, 2015
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE programRoberto Diletti, Hector M Garcia-Garcia, Christos Bourantas, et al.
JACC. Cardiovascular Interventions|August 18, 2022
FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: The FFR REACT TrialTara Neleman, Laurens J C van Zandvoort, Maria N Tovar Forero, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2026
Procedural Outcome of Modern Percutaneous Coronary Intervention in Proximal Chronic Total OcclusionsEmil N Holck, Guiseppe Vadalá, Mohamed Ayoub, et al.
American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 27, 2011
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology studySalvatore Brugaletta, Hector M Garcia-Garcia, Roberto Diletti, et al.
European Heart Journal|October 30, 2012
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trialVasim Farooq, Patrick W Serruys, Christos Bourantas, et al.
JACC. Cardiovascular Interventions|April 8, 2017
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main LesionsRichard J Jabbour, Akihito Tanaka, Piera Capranzano, et al.
Journal of the American College of Cardiology|July 9, 2011
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mmRoberto Diletti, Yoshinobu Onuma, Vasim Farooq, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 1, 2013
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trialsBill D Gogas, Christos V Bourantas, Hector M Garcia-Garcia, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 18, 2015
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE programRoberto Diletti, Hector M Garcia-Garcia, Christos Bourantas, et al.
JACC. Cardiovascular Interventions|August 18, 2022
FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: The FFR REACT TrialTara Neleman, Laurens J C van Zandvoort, Maria N Tovar Forero, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2026
Procedural Outcome of Modern Percutaneous Coronary Intervention in Proximal Chronic Total OcclusionsEmil N Holck, Guiseppe Vadalá, Mohamed Ayoub, et al.
American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 27, 2011
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology studySalvatore Brugaletta, Hector M Garcia-Garcia, Roberto Diletti, et al.
European Heart Journal|October 30, 2012
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trialVasim Farooq, Patrick W Serruys, Christos Bourantas, et al.
JACC. Cardiovascular Interventions|April 8, 2017
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main LesionsRichard J Jabbour, Akihito Tanaka, Piera Capranzano, et al.
Journal of the American College of Cardiology|July 9, 2011
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mmRoberto Diletti, Yoshinobu Onuma, Vasim Farooq, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 1, 2013
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trialsBill D Gogas, Christos V Bourantas, Hector M Garcia-Garcia, et al.
Pageof 24